577
242196226014562118175
Ces8507936014570127174
Urol10497936014578115180208
2021;12827936014562121178233249
25(4):15567936014562122153209240262
236–24318437936014562122182245300357415
PŘEHLEDOVÝ852207016974156235334409485586692777867
ČLÁNEK1757207016989163260360438521
17.850896013356104115
EAU988896013359128195
Guidelines:1207896013376136161223278304329389444487509
Prostate173989601336498158200237290326380
Cancer.2142896013369121182231284320337
[online]250489801313489147170191249302327
20212855898013159110160207
[cit308689801313479101134
16-8-2021]3263898013159106141196230276328377424446
Dostupné3750898013176135175210268327386439
z:421389801314969
https://uroweb430689801316496133193233250291321375406463541593653
org/gui‑497689801315991148188241299320353
deline/prostate‑cancer/85110480131601131351572142673073643964524925275766086596947457958539019529831018
18.8501196013356107130
Nordström10031196013377138174235278315350409501
T,1527119601336075
Akre16261196013372122160214
O,18631196013381100
Aly1987119601337197148
M,21591196013393117
Grönberg22991196013376112171232294350385446
H,27681196013377100
Eklund28911196013359109136196256318
M.32331196013393117
Prostate‑specific3374119801316091147187222271303354389429488543592614640666715
antigen41131198013155112144166225278336
(PSA)4473119801313488138200228
density47251198013165118175215236269321
in5070119801312885
the5179119801313997150
diagnostic850134801316082130189247305345380402450
algorithm1324134801315072132190222244278336425
of1773134801315887
prostate1884134801316192149189224273305356
cancer2264134801314999157206256288
Prostate2590134801315586142182217266298349
Cancer29641348013162112170218269301
Prostatic,3289134801315585142182217266298320369387
DiS3700134801317194143
2018;38861348013153105153199216
21(1):41261348013154101122170190207
57–6343571348013154104153210261
19.8501496013356105124
Arlen,998149601336499124179240262
PM,12841496013355140164
Bianco1471149601335782134194243302
F,1796149601335062
Dahut18811496013370122182242278
WL,21821496013390142165
et2370149601335288
al.248114960133507598
Prostate2603149801315282138178213262295345
Specific29731498013147106160209231257283332
Antigen33291498013161119150172231284342
Working36951498013187142174220244301360
Group4079149801316597154212271
guidelines43741498013156114135194247270291349402442
on48401498013155113
prostate4977149801315789146186220270302353
specific8501648013141100154204225251278327
antigen12011648013150107139161220273331
doubling15561648013160118176236259280338397
time1977164801313456145198
J22161648013138
Urol22781648013169100156180
2008;25001648013154105160214231
179:2755164801315498148167
218129461648013154101147195
20.8501796013356111133
Vickers1006179601336591140191244280324
AJ,13531796013370114135
Savage15111796013358111162214276330
C,1865179601336791
O’Brien19791796013379102161197223277338
MF,23411796013391145157
et2521179601335894
al.2639179601335681104
Systematic2767179801315499140174225314363395417465
review3257179801313587135158211289
of3570179801316290
pretreatment3685179801316395147180212263311343433486544576
prostatespecific4285179801316496152192227276308359400459513562584610637685
antigen49941798013153111143165224277335
velocity8501948013150102124182232253287338
and12121948013150108167
doubling14031948013160118176236259280338397
timeas1824194801313456145198246286
predictors2134194801316193144205227275311367399440
for2598194801312986118
prostate2740194801316193149189224273306357
cancer3121194801314998156205256287
J34461948013138
Clin3508194801316385106164
Oncol36961948013174133181237260
2009;39991948013153105160213232
27:42551948013153103117
398–40343961948013153104157213269324374
21.8502096013357108125
PRIAS9992096013366124151218273
Project12952096013367102162188243294332
[online].1651209601333996157183208269324352374
202120492098013162114164212
[cit2285209801313883105139
16-8-2021]24362098013154101136191226272324374422444
Dostupné29222098013179139179214272332391445
z:3391209801315373
https://prias‑project34882098013168100137197238255296326384416439487528559621653710733786836872
org/modules/articles/4379209801315991150189276335396453476529570609655686724746795817870911950
article850224801315081118140189211263
php?id=111312248013161119179215237296361407
22.8502396013356112135
Christensson10082396013363123158183226263316377420462523583
A,1615239601336691
Bjork1729239601335884144180231
T,1984239601335369
Nilsson2076239601337297122165207268328
O,2428239601337494
et2545239601335491
al.2659239601335277100
Serum27832398013150103135193282
prostate3089239801315991148188223272304355
specific3468239801314099153203225251277326
antigen38182398013149106138160219272330
complexed41722398013148104194253276329377428489
to4685239801313389
alpha4798239801314871130188237
150592398013153
anti‑51362398013149107138160193
chymotrypsin8502548013149107153243301334366417478518540597
as1471254801315090
an15852548013150108
indicator1717254801312380140162210260292348380
of2121254801315887
prostate2232254801316193149189224273305356
cancer2613254801314998156205256287
J29382548013138
Urol30002548013169100156179
1993;3222254801315499152202217
150:3464254801315398150168
100–10536562548013154101156214260308359
23.8502696013356112134
Catalona10072696013364117152205231291352404
WJ,14342696013394129150
Partin16072696013359110145185209270
AW,19002696013367156174
Slawin2097269601335480132211237297
KM,24172696013360150174
et2614269601335692
al.2729269601335479101
Use28552698013169107160
of3039269801315988
the3151269801313492145
percentage33202698013161115146193244302334383443496
of3840269801315987
free3951269801312962114167
prostate‑specific4142269801316193150190224274306357391432491545595616642669717
antigen48832698013151108140162221274332
to5239269801313490
enhance8502848013153110167216273321371
differentiation1245284801315677106135187218269326357379427458480537595
of1864284801315482
prostate1970284801315688144183217266298348
cancer2342284801314594151199250281
from2646284801312558114202
benign28722848013157110167189247304
prostatic3200284801315688144183217267298320368
disease:3591284801315677116168216255308325
a39402848013145
prospective4009284801315788144184242296344380402451502
multicenter45352848013185142163196218266316373405455486
clinical504528480131446687144166213262284
trial85029980131346688137159
JAMA1051299801313899184248
1998;1324299801315398152205222
279(19):15702998013154103154182230275301317
1542–15471911299801315499152201253299344397446
24.8503146013356109130
Stephan1004314601335084137199260312372
C,1399314601336084
Lein15063146013348102127187
M,17163146013384108
Jung1847314601333797157218
K,2088314601335681
et2192314601335187
al.230231460133507597
The24233148013147107159
influence2606314801311977102128185238295343394
of3024314801315482
prostate3130314801315789145185219268300350
volume35043148013146103126182271323
on38513148013155113
the3988314801313088140
ratio4152314801312978110132189
of4365314801315583
free4472314801312557109162
to4658314801313086
total4768314801313085117167189
prostate4980314801315789145185219268300351
specific8503298013141100154204225251278327
antigen12013298013155113144166225278336
in1561329801312986
serum16713298013147100131189278
of1973329801316492
patients20893298013166116149171223281313355
with24683298013184107140198
prostate2690329801316698155195229279311362
carcinoma30763298013155104136182204262320409458
and35583298013156113173
benign37553298013166120178200259316
prostate4096329801316597154194229278310361
hyperplasia44813298013165111172226257317341389429450498
Cancer50223298013168118176225275307
1997;850344801315499152202215
79:10893448013154104123
10412363448013154101156
25.8503596013356112133
Huang10063596013375135188248309
Y,1339359601336277
Li1439359601335580
ZZ,15433596013364125148
Huang17153596013374135187247309
YL,20473596013362115138
et2208359601335895
al.2326359601335682104
Value24543598013159106128185238
of2716359801316290
free/total2830359801313265117171210243299331381403
prostate‑specific3257359801316496153193227277309360395435495549598620646672721
antigen40023598013153111142165224277334
(f/t436135980131325894127
PSA)45123598013159108171198
ratios4735359801313585117139197237
for4996359801313289121
pro‑5141359801316496153188
state850374801314176125157208
cancer10823748013154104162211261293
detection13993748013165118151202251287309367426
in1849374801312885
patients19583748013166116148170223281313354
with23363748013185107141199
total2559374801313995127177199
serum2782374801314699131189278
prostate‑specific3084374801316698154194229278310361396436496550599621647673722
antigen38303748013155113144167226278336
between41903748013166120153235287341399
446133748013159
and46963748013155112172
1048923748013159106
ng/mL:50223748013154113152239287307
A8503898013164
metaanalysis9383898013191144177226275333382404452492514553
Medicine15343898013186139199221270291349402
(Baltimore)1960389801312983133156189211300358390441467
2018;24513898013153105153199216
97:26913898013154104117
024928323898013154103151201
26.8504046013356110133
Fiala1006404601335882134160212
V,1241404601336581
Hanuš13464046013375128189248291
T,1660404601335974
Čapoun17584046013367120182243304364
O,21454046013380100
et2268404601335995
al.2387404601335682104
Zkušenosti25164048013163108166206258316375415449471
s30114048013145
použitím30804048013165124182226249282304393
indexu3497404801312784144197244302
zdraví38234048013149107138188235258
prostaty4105404801316597154194228278310361
v44904048013154
klinické456840480131507596154175224269321
praxi4913404801316496146194217
Ces51724048013166117158
Urol8504198013169100156179
2017;10534198013154106153197210
21(4):12874198013154101122172197214
284–28815254198013154105160217264315369
27.8504346013356109121
Le9944346013356110
BV,11274346013364124140
Griffin12904346013375111136166196226286
CR,15994346013368126150
Loeb17734346013356115170233
S,2029434601335881
et2133434601335995
al.2252434601335782104
[-2]2381434801313363109135
Proenzyme2540434801315990146200258302354444498
prostate3062434801316496153193227277309360
specific34464348013145104158208230256282331
antigen38014348013154111143165224277335
is4160434801312766
more42504348013194153185236
accurate45104348013154103149207238288320371
than4905434801313896145203
total5132434801313894126176198
and8504498013150108167
free1041449801312861113166
prostate1231449801316092149189223273305356
specific1611449801314099153203225250277326
antigen19614498013149106138160219272330
in2315449801312280
differentiating2419449801315981110139191223274332364386434467489546606
prostate3049449801315991148188222272304355
cancer3428449801314898156204255287
from3739449801312861117207
benign39704498013160114172193252310
disease4304449801315981120173221261314
in4642449801312279
a47454498013149
prospective4819449801315991148188247301350387409458510
prostate850464801316193149189224273306357
cancer1231464801314998156205256287
screening1542464801314190121173227285306364423
study1989464801314176134193241
J22684648013138
Urol2330464801316999156179
2010;25524648013153105153200218
183:27944648013154100152167
1355–13592985464801315499148197252299343393441
28.8504796013356111135
Lazzeri10084796013352106153203258293319
M,13504796013389113
Haese14864796013372125180223278
A,1787479601336792
Abrate19024796013368130166219254308
A,2233479601336792
et2348479601335692
al.2463479601335479101
Clinical2589479801316385106164186234284306
performance29194798013161115146178235267357406464512563
of3506479801315987
serum3618479801314194125183272
prostate3914479801316193150190224274306357
specific42954798013141100154204226252278327
antigen46464798013150108139162221273331
isoform5001479801312463121149206238328
[−2]proPSA850494801312991138163222254311366415478
(p2PSA)1352494801313191141194243306333
and17104948013152109169
its1903494801312559100
derivatives20274948013162115147169219268300323372424464
%p2PSA25154948013183144194246296358
and28974948013153110170
the3091494801313694147
prostate3262494801316395152192226276308359
health36454948013161114162185218276
index3945494801312583142195243
(phi)4212494801313191150172199
in4436494801312582
men45424948013193146204
with47704948013181104137195
a49904948013152
family5066494801313181170192214262
history850509801315981120154210242294
of1168509801316593
prostate1285509801316799155195230280312363
cancer:16725098013155105162211262293313
results2009509801313990130187209242284
from2317509801313568124214
a25555098013156
multicenter26355098013196153176209231279330388420471502
European31615098013157113144200261315363421
study,3606509801314781139198247260
the3890509801314098151
PROMEtheuS40655098013161115188272323354412465522572
project4661509801316698155177230280316
BJU5020509801316198166
Int5210509801312987119
2013;8505248013154105153198213
112:1087524801315495139157
313–32112685248013154100145200249297345
29.8505396013356111130
Ryšánková10045396013360113156209270321379431484
K,1511539601336186
Bartoš16215396013360114149188247290
V,1934539601336378
Krhut2036539601336198158218254
J,2313539601334263
et2400539601335692
al.2516539601335479102
(-2)proPSA2642539801313060106132191223280335385447
a31135398013151
Index3188539801312582142195243
zdravé34555398013145103134184232284
prostaty3763539801316294150190225275307358
(PHI)4145539801313084151174201
v43705398013151
predikci4445539801316294146206228273320342
výskytu48115398013151103143188240277335
kar‑5170539801314899130159
cinomu851554801314971128187276333
prostaty1208554801316193150190224274306357
v15895548013150
transrektálních1663554801313466116174213244295341378428450507529577634
biopsiích2322554801316083141201241262284332389
Ces27545548013163114154
Urol2933554801316899156179
2018;31365548013154105153199216
22(1):33765548013154107132179200216
40–4736165548013154109167223271
30.8515696013356112133
Fuchsová10085696013354111160220263323374427
R,1459569601335984
Topolčan15665696013355108171232258307360420
O,2009569601337696
Hora21285696013372133169222
M,23735696013389113
et2509569601335692
al.2624569601335479101
Přínos2749569801315686108166224264
stanovení3037569801314276126184242290342400422
[-2]proPSA3483569801312959105131189221278333383445
v39525698013150
diferenciální4026569801316082110163194246303352374422444502523
diagnostice4573569801316182131190248306346381403451502
karci‑5099569801314798129176197230
nomu8515848013159117207264
prostaty1139584801316193149189224273306357
Ces15335848013163114154
Urol1712584801316899156179
2014;19155848013154105153199216
18(1):21555848013154100128176196213
21–2523925848013153100150197250
31.8515996013356106123
Catalona9985996013363116151205230290351403
W,14255996013393110
Partin15595996013358109145184209269
A,1851599601336892
Bangma19675996013359112173234325377
C,2368599601336388
et2479599601335591
al.2594599601335278100
A27185998013164
multicenter28065998013190148170203225273324382414465496
study3326599801314176133193241
of3591599801315987
[-2]pro‑prostate3702599801312959105131189221278313374406462502537587619670
specific43965998013141100154203225251278326
antigen47465998013150108140162221274332
com‑51025998013149105194228
bined851614801316183141194254
with11296148013185107140198
prostate1352614801316597154194228278310361
specific17376148013146105159209230256283331
antigen20926148013155113145167226279337
and24536148013155112172
free2649614801313466118172
prostate2845614801316597154194228278310361
specific32306148013146105159209231257283332
antigen35866148013155112144166225278336
for3946614801313491123
prostate4093614801316698154194229278310361
cancer44786148013154104162210261293
detection47956148013165117150201251287309367425
in5245614801312785
the851629801313492145
210206298013154
010916298013154
to1169629801313490
1012836298013154101
014016298013154
ng/ml14796298013154113153239261
prostate1764629801316193149189224274306357
specific21456298013141100154203225251278326
antigen24956298013150108140162221274332
range2851629801313282140199252
J31456298013137
Urol3207629801316899156179
2011;34106298013154105153194204
185:36386298013154100152167
1650–165538296298013154100151203261307354405454
32.8506447013356109132
Haese10056447013372125180223278
A,1307644701336792
Graefen14226447013372108161216248303364
M,18096447013389113
Steuber1945644701335488142203264320356
T,2324644701335571
et2418644701335692
al.2533644701335479101
Human26596448013170127216265323
glandular3006644801316082131188248305327376407
kallikrein3437644801314798120141163208241293315372
238336448013154
levels3912644801312376125177199238
in4174644801312381
serum4279644801314194126184273
for4576644801312986118
discrimination4718644801316182121170202224313335392441473495553611
of850659801315987
pathologically9616598013163113145203262285343403425473523545567615
organconfined1600659801316193151200257306362420446473530583643
from2267659801313265121211
locally‑advanced2502659801312684133183205227275308356416465515573622672733
prostate3259659801316395152192226276308359
cancer36426598013152101159208258290
in3956659801312583
total4063659801313793125175197
PSA‑levels42846598013158107170202226278327379402440
below47486598013164118140198277
1050496598013156103
ng/51766598013154113153
ml8506748013190112
Prostate1005674801315586142182217266298349
2001;13786748013154106161208219
49(2):16216748013154104132183209226
101–10918716748013154101149198244291345
33.8506896013356109131
Gupta10046896013367128190226279
A,1306689601336488
Roobol14176896013356116177239300326
MJ,17666896013385126147
Savage19366896013351104155207268323
CJ,22826896013360103124
et2430689601335187
al.254168960133497497
A26626898013161
four‑kallikrein2747689801312582140171200246297319341362407440492514571
panel33426898013157107165217240
for3606689801312582114
the3744689801313088141
prediction3909689801315789140201222270306328386444
of4377689801315583
repeat4484689801312981140194242274
prostate4782689801315789145185220269301352
bio‑5158689801315779137171
psy:8507048013161101150169
data10447048013158106139188
from1256704801312760117206
the1487704801313290143
European16547048013149105136193253307355413
Randomized20917048013154103161220278368390434485545
Study2661704801314980138197245
of2930704801315786
Prostate3040704801315384140180215264296347
Cancer34127048013160110168217267299
screening3735704801313988119171225283304362421
in4180704801312279
Rotterdam,42837048013154112145181232264321370459477
Netherlands47847048013169122155213266297320369427486526
Br850719801315687
J9617198013138
Cancer10237198013163113171219270301
2010;13487198013154106153201219
103(5):15917198013154101151177228255271
708–71418867198013154104158214262310357
34.8507346013356112135
Novák10087346013368129180233283
V,1314734601335874
Veselý14117346013358108151206232283
Š.1717734601335171
PSA18127348013151101163
a19997348013146
jeho2069734801312072130188
izoformy2281734801311963119147204236326372
jako2677734801311967113169
moderní28707348013186145205257289347369
markery32637348013186134165211263294346
karcinomu3633734801314293124171192249307397454
prostaty4111734801315788145184219268300351
Ces45007348013159110150
Urol4674734801316596152175
2019;48737348013150101148193211
23(3):51087348013150103129179204221
194–202850749801315499153210257309358